|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A2049 Batch: A204901
Evinacumab is a monoclonal antibody that targets, binds to, and pharmacologically inhibits ANGPTL3, which can act as a complementary agent to other LDL-C lowering regimens for patients aged 12 or older with HoFH.
| CAS No. | 1446419-85-7 |
|---|---|
| Formulation | PBS Buffer, PH 7.4 |
| Isotype | human IGg1, λ |
| Application | Evinacumab(anti-ANGPTL3) |
| Source | CHO |
| Storage (From the date of receipt) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles |
| Shipping | Shipped under low temperature conditions |
| Purity | 98% |
| Protein concentration | 4.6mg/ml |
| Endotoxin Level | <2 EU/mg |
.gif)
人間や獣医の診断であるか治療的な使用のためにでない。